Rivulet Media Inc (fka RIVU)

[rusty8350]

Medistem, or MEDS, is a very important company to bring up in our discussion of BMSN. Our science is comparable, we both have a great team of well respected medical scientists, and if you look at a chart, MEDS traded in PENNY LAND during 2009, 2010, 2011, and some of 2012. Their stock is now at $2.50 a share. Think about this one for awhile.

Medistem, Inc. engages in the development and commercialization of adult stem cell therapies in the United States. The company is developing endometrial regenerative cell (ERC), a universal donor stem cell product that promotes new blood vessel formation (angiogenesis), reduce inflammation, regulate immune system function, and augment tissue repair and healing. It is developing ERCs to treat a range of diseases, including ischemic conditions, cardiovascular and neurological diseases, kidney failure, liver failure, pulmonary diseases, and orphan disease indications, as well as autoimmune diseases, such as type 1 diabetes. The company was formerly known as Medistem Laboratories, Inc. and changed its name to Medistem, Inc. in August 2008. Medistem, Inc. is headquartered in San Diego, California.